The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.

In May of this year, AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate)—already licensed to ...

Company has launched its 150,000 sq ft UK headquarters at Charnwood Campus, where it will develop next-generation propellants ...

The risk for a severe exacerbation was decreased among patients with asthma using high-dose ICS/LABA vs medium-dose ICS/LABA.

Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...

Drones have been piloted across the country, including in the delivery of vital chemotherapy drugs to the Isle of Wight, reducing a 4-hour journey time by road and sea to a 30-minute flight, ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...

Soft Mist Inhalers market expected to grow at a CAGR of 6.8% from 2023 to 2031 and reach more than £4.4 Bn by the end of 2031.

For decades, chronic respiratory diseases (CRDs) such as asthma and chronic obstructive pulmonary disease (COPD) have been treated as a “Cinderella” issue in global health—a silent epidemic that ...

The weekly combination therapy is intended for adults with poor glucose control despite basal insulin or GLP-1 receptor agonist treatment.

The global intelligent asthma monitoring devices market was US$ 225.8 million in 2021. The global intelligent asthma monitoring devices market is forecast to reach US$ 1,696.7 million by 2030, growing ...

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Merck & Co., Inc. is placed fourth among them. Merck & Co., Inc. (NYSE:MRK), a global ...